Login / Signup

A Bayesian Approach for Population Pharmacokinetic Modeling of Pegylated Interferon α-2a in Hepatitis C Patients.

Mohammad I Saleh
Published in: Clinical pharmacokinetics (2018)
NV15942 and NV15801.
Keyphrases
  • end stage renal disease
  • chronic kidney disease
  • ejection fraction
  • newly diagnosed
  • peritoneal dialysis
  • dendritic cells
  • immune response
  • recombinant human